Been on it for two years without an issue. The nice thing with Siponimod, you ramp up so no monitoring like was required for Gilenya. Good luck for you and hope it slows down your disability progression.
June 14, 2025
Siponimod (Mayzent) is an FDA-approved medication specifically designed to treat Secondary Progressive MS. Clinical trials have shown promising results, with the medication reducing the risk of worsening disability by 21% and decreasing relapse risk by 55%.
The medication works by preventing white blood cells from entering Show Full Answer
Siponimod (Mayzent) is an FDA-approved medication specifically designed to treat Secondary Progressive MS. Clinical trials have shown promising results, with the medication reducing the risk of worsening disability by 21% and decreasing relapse risk by 55%.
The medication works by preventing white blood cells from entering your central nervous system, which helps reduce inflammation and protects nerve cells from further damage. Common side effects you may experience include:
- Headaches
- Urinary tract infections
- Falls
- Common colds
It's important to take this medication exactly as prescribed by your healthcare provider. The medication is taken orally, and your neurologist will discuss specific dosing instructions and potential side effects during your consultation.
AI-generated responses are not a substitute for medical advice. These services are not intended to
diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.
Secondary Progressive Multiple Sclerosis Explained
June 14, 2025
Join
Your Privacy Choices
